During the past decade, Ospedale San Giovanni Bosco conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale San Giovanni Bosco" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Italian Society of Invasive Cardiology" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored, "Azienda Ospedaliera Città della Salute e della Scienza di Torino" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale San Giovanni Bosco" #1 collaborator was "Eustrategy" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale San Giovanni Bosco" are "Coronary Artery Disease" (5 trials), "Rheumatoid Arthritis" (4 trials), "Acute Coronary Syndrome" (3 trials), "Coronary Artery Restenosis" (2 trials) and "Coronary Artery Stenosis" (2 trials). Many other conditions were trialed in "Ospedale San Giovanni Bosco" in a lesser frequency.

Most popular intervention types in "Ospedale San Giovanni Bosco" are "Drug" (16 trials), "Device" (6 trials), "Procedure" (4 trials), "Diagnostic Test" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (3 trials), "Baricitinib" (2 trials), "Bendamustine" (2 trials), "Obinutuzumab" (2 trials) and "Aspirin 100 mg OD plus clopidogrel 75 mg OD" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale San Giovanni Bosco" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale San Giovanni Bosco". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Ospedale San Giovanni Bosco, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale San Giovanni Bosco, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 2 trials that are defined as “Not Applicable".